This annual conference discusses the expanding Point-of-Care Diagnostics and Global Health fields and bring in the Biosensors field providing the most up-to-date presentations from leaders in these fields and offer networking and engagement opportunities with delegates from around the world.
This conference provides an overview of the point-of-care (POC) testing landscape, from novel technologies to regulatory approval. Experts in these fields will share their views on point-of-care in the clinical setting. The aim of this meeting is to bring together life science researchers that work at the interface between biology and chemistry and technology development to discuss problems, highlight solutions and facilitating collaborations. Also, we frame the role of POC testing in the expanding Global Health field and highlight opportunities existing in many parts of the world.
This conference covers POC Detection, POC Diagnostics, and POC-based Treatment Options as part of the Comprehensive Coverage of this Expanding Field. The POC testing field is expanding focused not only on infectious disease diagnostics (which represents approximately 80% of the marketplace) but also with cancer and cardiovascular disease focus. We address each of these segments in this conference.
Registered delegates have full access to the co-located and concurrent conferences to mix-and-match presentations and maximize networking:
- Lab-on-a-Chip and Microfluidics: Emerging Themes, Technologies and Applications 2019
- Lab-on-a-Chip and Microfluidics: Technologies, Companies and Commercialization 2019
- Point-of-Care Diagnostics and Global Health 2019
- Single Cells, Single Molecules & Vesicles Summit 2019
- Microfluidics and Flow Chemistry 2019
The Conference Features the Following Panel Discussions:
- Global Health Panel Discussion Chaired by Amy Adelberger (CEO, Global Impact Advisors).
- POC Diagnostics to the Market - A Panel Discussion of Industry Participants" Chaired by John Brennan (Professor and Director, McMaster University).
*Please Note: Academic pricing provided on enquiry.
- Emerging Technologies and Emerging Companies Showcase
- Global Health and Emerging Viral Diseases such as Ebola and Zika
- Impact of Microfluidics/Lab-on-a-Chip Technologies for Point-of-Care (POC) Diagnostics Applications
- Microfluidics for Wearables and Mobile Diagnostics Development
- POC Diagnostics for Global Health: A Worldwide Perspective
- Low-Cost POC Devices for Deployment Worldwide
- POC Diagnostics in Resource-Limited Settings
- POC Diagnostics in Infectious Disease Testing
Mr Paul Yager,
University of Washington
Paul Yager is Professor at the Department of Bioengineering, University of Washington.
Mr Arben Merkoçi,
ICREA Research Professor And Group Leader ,
Catalan Institute of Nanoscience And Nanotechnology
Arben Merkoçi is ICREA Professor and director of the Nanobioelectronics and Biosensors Group at Catalan Institute of Nanoscience and Nanotechnology (ICN2), in Barcelona. His research is focused on the design and application of cutting edge nanotechnology and nanoscience based biosensors. These nanobiosensors are based on the integration of biological molecules (DNA, antibodies, cells and enzymes) and other (bio)receptors with micro- and nanostructures and applied in diagnostics, environmental monitoring or safety and security. He has published around 200 peer review research papers, is editor of books and special journals issues dedicated to the field of nanomaterials integration and applications in biosensors.
Mr Joseph Wang,
Chair of Nanoengineering, SAIC Endowed Professor ,
Director at Center of Wearable Sensors, University of California-San Diego
Professor Joseph Wang, is currently SAIC Endowed Chair and Distinguished Professor in the Department of Nanoengineering at University of California, San Diego. Previously, he was a Professor of the Department of Chemical Engineering at Arizona State University (ASU) and Director of Center for Bioelectronics and Biosensors at the Biodesign Institute. He obtained his higher education at the Technion and being awarded his D. Sc. in 1978. From 1978 to 1980 he served as a research associate at the University of Wisconsin (Madison) and joined New Mexico State University (NMSU) at 1980. From 2001-2004, he held a Regents Professorship and a Manasse Chair positions at NMSU. Since 1980, 20 Ph.D. candidates and 130 research associates and visiting scholars have studied with Professor Wang.
Prof. Wang's research focuses on field of nanobioelectronics and nanorobotics. Wang’s interests include nanomotors, nanorobotics and nanoactuators, nanoscale barcodes, nanomedicine, wearable on body sensors and biofuel cells, bioelectronic detection of proteins and nucleic acids, microfabrication, self-assembly of nanostructures, microfluidic devices (Lab-on-a-chip), nanoparticle-based bioassays, bionanomaterials, management of diabetes, point-of-care clinical development of electrochemical sensing devices for clinical and environmental monitoring, on-body glucose biosensors, new surfaces and interfaces, sensor/recognition coatings, remote sensing, the development of techniques for ultra trace measurements and the design of on-line flow detectors. Prof. Wang's contributions have greatly enhanced the power and scope of applications of nanomachines and have had major impacts upon the fields of wearable sensors, the use of nanomaterials in bioanalysis, and upon the growing popularity of electroanalytical techniques.
University of Cincinnati
Distinguished University Research Professor, Mitchell P. Kartalia Chair Professor of BioMEMS, University of Cincinnati
University of Califonia - Santa Cruz
Narinder Kapany Professor of Electrical Engineering, University of California-Santa Cruz
University of Notre Dame
Arthur J. Schmitt Professor of Chemical and Biomolecular Engineering and Professor of Chemistry and Biochemistry, University of Notre Dame
Califonia Institute of Technology
Ethel Wilson Bowles and Robert Bowles Professor of Chemistry and Chemical Engineering, California Institute of Technology
Professor & Director ,
Biointerfaces Institute, McMaster University
Professor and Director, Biointerfaces Institute, McMaster University
New York University College of Dentistry Bioengineering Institute
Chair, Department Biomaterials, New York University College of Dentistry Bioengineering Institute
In Vitro Diagnostics, Global Good fund at Intellectual Ventures
Director, Center for In-Vitro Diagnostics, Intellectual Ventures/Global Good-Bill Gates Venture Fund
- Senior Academic researchers involved in research and technology development
- Senior Industry researchers involved in R&D
- Business Development professionals in companies involved in technology evaluation, licensing and partnering/business development activities
- Young investigators/researchers embarking on their research careers - excellent opportunity to learn the latest science and excellent networking opportunities to build collaborations
- Students and post-doctoral fellows - opportunity to present their research to a worldwide audience via posters and build their professional networks, collaborations, and career development
Coronado Island Marriott Resort & Spa
2000 2nd St
San Diego, CA